$65.1 Billion Prevention and Treatment of Prostate Cancer: Technologies and Global Markets – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Prevention
and Treatment of Prostate Cancer: Technologies and Global Markets”

report to their offering.

The report includes an overview of the market for the prevention and
treatment of prostate cancer, with coverage of the mechanisms of disease
development, detection and diagnosis, and anticancer agents. It provides
analyses of global market trends, with data from 2012, 2016, and
projections of compound annual growth rates (CAGRs) through 2021.

It contains discussion of risk factors, natural history, epidemiology,
and the genetics of prostate cancer. As well as examinations of
prostate-specific antigen (PSA) screening, including the causes of PSA
changes, PSA thresholds, and controversies over the screening.

It provides coverage of emerging therapies, including combination
therapy, therapeutic vaccines, inhibitors of kinase signaling pathways,
proteasome inhibitors, angiogenesis inhibitors, and immunotherapeutic

The scope of this study is testing, screening technology and also
therapeutics markets for prostate cancer. The report also includes the
regulatory environment, current technologies, new technologies, prostate
cancer incidence, market projections and market share, along with latest
trends and new developments.

Screening for diagnosis, therapy via drug, surgery or radiation is
measured and broken down by PSA testing, digital rectal exam (DRE),
prostate biopsy, hormone therapy, chemotherapy, immunotherapy, external
beam radiation therapy (EBRT), prostatectomy and brachytherapy.

Companies Mentioned

  • Abbott Laboratories
  • Active Biotech AB
  • Algeta
  • Amgen
  • Bavarian Nordic A/S
  • Bayer HealthCare Pharmaceuticals
  • Bristol-Myers Squibb
  • C.R. Bard
  • Others

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Overview

4: Prostate Cancer Information

5: Prostate Cancer Screening and Diagnosis

6: Prostate Cancer: Therapeutic Interventions

7: Prostate Cancer Therapeutics in the Global Market

8: Global Burden of Cancer

9: Prostate Cancer and Diagnostic Market

10: Prostate Cancer Treatment Market

11: Prostate Cancer Drugs Market

12: Emerging Prostate Cancer Drugs

13: Prostate Cancer Patents

14: Selected Company Profiles

15: References and End Notes

For more information about this report visit http://www.researchandmarkets.com/research/969rnj/prevention_and


Research and Markets
Laura Wood, Senior Manager
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Topics: Prostate
Cancer Drugs